Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China

References

• Onishchenko K, Hill S, Wasserman M, Jones C, Moffatt M, Ruff L, Pugh SJ. Trends in vaccine investment in middle income countries. Hum Vaccin Immunother. 2019;15(10):2378–9. doi:10.1080/21645515.2019.1589287.
   PubMed Web of Science ®Google Scholar
• Ehreth J. The global value of vaccination. Vaccine. 2003;21(7–8):596–600. doi:10.1016/S0264-410X(02)00623-0.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Essential programme on immunization. [accessed 2023 Jun 9]. https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization.
   Google Scholar
• Obando-Pacheco P, Rivero-Calle I, Gomez-Rial J, Rodriguez-Tenreiro Sanchez C, Martinon-Torres F. New perspectives for hexavalent vaccines. Vaccine. 2018;36(36):5485–94. doi:10.1016/j.vaccine.2017.06.063.
   PubMed Web of Science ®Google Scholar
• Wagner AL, Boulton ML, Sun XD, Huang ZY, Harmsen IA, Ren J, Zikmund-Fisher BJ. Parents’ concerns about vaccine scheduling in Shanghai, China. Vaccine. 2017;35(34):4362–7. doi:10.1016/j.vaccine.2017.06.077.
   PubMed Web of Science ®Google Scholar
• Aljunid SM, Al Bashir L, Ismail AB, Aizuddin AN, Rashid S, Nur AM. Economic impact of switching from partially combined vaccine “Pentaxim® and hepatitis B” to fully combined vaccine “Hexaxim®” in the Malaysian National Immunization Program. BMC Health Serv Res. 2022;22(1):1–12. doi:10.1186/s12913-021-07428-7.
   PubMed Web of Science ®Google Scholar
• Maman K, Zollner Y, Greco D, Duru G, Sendyona S, Remy V. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother. 2015;11(9):2132–41. doi:10.1080/21645515.2015.1044180.
   PubMed Web of Science ®Google Scholar
• Kurosky SK, Davis KL, Krishnarajah G. Effect of combination vaccines on completion and compliance of childhood vaccinations in the United States. Hum Vaccin Immunother. 2017;13:2494–502.
   PubMed Web of Science ®Google Scholar
• Lloyd AJ, Nafees B, Ziani E, Nicolas L, Fordham BA, Soubeyrand B, Fordham B. What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution? Patient Preference And Adherence. 2015;1517–24. doi:10.2147/PPA.S87229.
   PubMed Web of Science ®Google Scholar
• Min S, Kwon SH, Lee YW, Lee JM, Bae EJ, Lee EK. Estimating the total societal cost of a hexavalent vaccine versus a pentavalent vaccine with hepatitis B in South Korea. Nato Adv Sci Inst Se. 2023;11(5):11. doi:10.3390/vaccines11050984.
   Google Scholar
• Mathijssen DAR, Heisen M, Clark-Wright JF, Wolfson LJ, Lu X, Carrol S, van Dijk BCP, Klijn SL, Alemayehu B. Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom. Expert Review Of Vaccines. 2020;19(12):1167–75. doi:10.1080/14760584.2020.1873770.
   PubMed Web of Science ®Google Scholar
• Xie JG, Zhao LL, Zhou SB, He YQ. Statistical and ontological analysis of adverse events associated with monovalent and combination vaccines against hepatitis A and B diseases. Sci Rep. 2016;6(1):6. doi:10.1038/srep34318.
   PubMedGoogle Scholar
• Elliman D, Bedford H. Safety and efficacy of combination vaccines: combinations reduce distress and are efficacious and safe. BMJ. 2003;326(7397):995–6. doi:10.1136/bmj.326.7397.995.
   PubMedGoogle Scholar
• Reportlinker. A white paper to understand the market structure of pediatric pertussis combination vaccines. [accessed 2021 Nov 19]. https://ai.reportlinker.com/hubfs/Guide/market-study-on-dtap-ipv-based-vaccines.pdf.
   Google Scholar
• Syed YY. DTaP-IPV-HepB-Hib vaccine (Hexyon®): an updated review of its use in primary and booster vaccination. Pediatr Drugs. 2019;21(5):397–408. doi:10.1007/s40272-019-00353-7.
   PubMed Web of Science ®Google Scholar
• European Commission. Public Health -Union register of medicinal products. European commission. [accessed 2024 Jan 18]. https://ec.europa.eu/health/documents/community-register/html/h829.html.
   Google Scholar
• Jamnani AS, Rezapour A, Moradi N, Langarizadeh M. Willingness to pay for and acceptance of cervical cancer prevention methods: a systematic review and meta-analysis. Med J Islam Repub Iran. 2021;35:81.
   PubMedGoogle Scholar
• National Bureau of Statistics of China. Statistical system and classification criteria. [accessed 2023 Oct 9]. https://www.stats.gov.cn/hd/cjwtjd/202302/t20230207_1902279.html.
   Google Scholar
• CDC Weekly C, National Health Commission of China. Childhood immunization schedule for national immunization program vaccines—China (version 2021). China CDC Wkly. 2021;3(52):1101. doi:10.46234/ccdcw2021.270.
   PubMedGoogle Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (London, Engl). 2007;370(9596):1453–7. doi:10.1016/S0140-6736(07)61602-X.
   PubMed Web of Science ®Google Scholar
• Lin Y, Lin Z, He F, Chen H, Lin X, Zimet GD, Alias H, He S, Hu Z, Wong LP. et al. HPV vaccination intent and willingness to pay for 2-, 4-, and 9-valent HPV vaccines: a study of adult women aged 27–45 years in China. Vaccine. 2020;38(14):3021–30. doi:10.1016/j.vaccine.2020.02.042.
   PubMed Web of Science ®Google Scholar
• Harapan H, Mudatsir M, Yufika A, Nawawi Y, Wahyuniati N, Anwar S, Yusri F, Haryanti N, Wijayanti NP, Rizal R. et al. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: a cross-sectional study in Indonesia. Vaccine. 2019;37(11):1398–406. doi:10.1016/j.vaccine.2019.01.062.
   PubMed Web of Science ®Google Scholar
• Yeo HY, Shafie AA. The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study. Cost Eff Resour Alloc. 2018;16(1):60. doi:10.1186/s12962-018-0163-2.
   PubMedGoogle Scholar
• Zheng YM, Rodewald L, Yang J, Qin Y, Pang MF, Feng LZ, Yu H. The landscape of vaccines in China: history, classification, supply, and price. BMC Infect Dis. 2018;18(1):18. doi:10.1186/s12879-018-3422-0.
   PubMedGoogle Scholar
• Harapan H, Wagner AL, Yufika A, Setiawan AM, Anwar S, Wahyuni S, Asrizal FW, Sufri MR, Putra RP, Wijayanti NP. et al. Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: a cross-sectional study in Indonesia. Vaccine. 2020;38(43):6800–6. doi:10.1016/j.vaccine.2020.08.034.
   PubMed Web of Science ®Google Scholar
• O’brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant. 2007;41(5):673–90. doi:10.1007/s11135-006-9018-6.
   Web of Science ®Google Scholar
• Qin W, Wang E, Ni Z, Gao Z. Chinese consumers’ willingness to get a COVID-19 vaccine and willingness to pay for it. PloS One. 2021;16(5):e0250112. doi:10.1371/journal.pone.0250112.
   PubMed Web of Science ®Google Scholar
• Onukwugha E, Bergtold J, Jain R. A primer on marginal effects—part II: health services research applications. Pharmacoeconomics. 2015;33(2):97–103. doi:10.1007/s40273-014-0224-0.
   PubMed Web of Science ®Google Scholar
• Lu XY, Ji MD, Wagner AL, Huang WF, Shao XP, Zhou WY, Lu Y. Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey. BMC Health Serv Res. 2022;22(1):22. doi:10.1186/s12913-022-08716-6.
   PubMed Web of Science ®Google Scholar
• Li L, Ma Y, Li W, Tang G, Jiang Y, Li H, Jiang S, Zhou Y, Yang Y, Zhang T. et al. Caregiver willingness to vaccinate children with pneumococcal vaccines and to pay in a low-resource setting in China: a cross-sectional study. Nato Adv Sci Inst Se. 2022;10(11):1897. doi:10.3390/vaccines10111897.
   Google Scholar
• Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H, Knoll MD, Fang H. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine. 2021;39(14):1968–76. doi:10.1016/j.vaccine.2021.02.060.
   PubMed Web of Science ®Google Scholar
• Lai XZ, Rong HG, Ma XC, Hou ZY, Li SP, Jing RZ, Zhang H, Peng Z, Feng L, Fang H. et al. Willingness to pay for seasonal influenza vaccination among children, chronic disease patients, and the elderly in China: a national cross-sectional survey. Nato Adv Sci Inst Se. 2020;8(3):8. doi:10.3390/vaccines8030405.
   Google Scholar
• Li J, Chen S, Asturias E, Tang S, Cui F. Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action. Infect Dis Poverty. 2024;13(1):1–11. doi:10.1186/s40249-024-01181-9.
   PubMed Web of Science ®Google Scholar
• Xu JN, Cui YJ, Huang CC, Dong YY, Zhang YT, Fan LC, Li G, Jiang F. Prevalence and factors associated with pentavalent vaccination: a cross-sectional study in Southern China. Infect Dis Poverty. 2023;12(1):12. doi:10.1186/s40249-023-01134-8.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L. Status of public–private partnership recognition and willingness to pay for private health care in China. Int J Health Plann Manage. 2019;34(2):e1188–e99. doi:10.1002/hpm.2757.
   PubMed Web of Science ®Google Scholar
• Wang Y, Meng F, Li J, Li G, Hu J, Cao J, Yu, Q, Liang, Q, Zhu, F. Willingness of parents to vaccinate their 6–60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province. Hum Vaccines Immunother. 2020;16:1579–85. doi:10.1080/21645515.2020.1737465.
   PubMed Web of Science ®Google Scholar
• Ganczak M, Dmytrzyk-Daniłów G, Karakiewicz B, Korzeń M, Szych Z. Determinants influencing self-paid vaccination coverage, in 0–5 years old Polish children. Vaccine. 2013;31(48):5687–92. doi:10.1016/j.vaccine.2013.09.056.
   PubMed Web of Science ®Google Scholar
• Huang ZY, Wagner AL, Lin MZ, Sun XD, Zikmund-Fisher BJ, Boulton ML, Ren J, Prosser LA. Preferences for vaccination program attributes among parents of young infants in Shanghai, China. Hum Vaccines Immunother. 2020;16:1905–10. doi:10.1080/21645515.2020.1712937.
   PubMed Web of Science ®Google Scholar
• Tarekegn AA, Yismaw AE. Health professionals’ willingness to pay and associated factors for human papilloma virus vaccination to prevent cervical cancer at College of Medicine and Health Sciences University of Gondar, Northwest Ethiopia. BMC Res Notes. 2019;12(1):1–6. doi:10.1186/s13104-019-4085-7.
   PubMedGoogle Scholar
• National Bureau of Statistics of China. Per capita disposable income in China. [accessed 2023 Jul 18]. http://www.stats.gov.cn/sj/sjjd/202307/t20230718_1941321.html.
   Google Scholar
• Saxenian H, Alkenbrack S, Attaran MF, Barcarolo J, Brenzel L, Brooks A, Ekeman E, Griffiths UK, Rozario S, Maele NV, et al. Sustainable financing for Immunization Agenda 2030. Vaccine. 2022. doi:10.1016/j.vaccine.2022.11.037.
   PubMedGoogle Scholar
• Zhou HJ, Pan L, Shi H, Luo JW, Wang P, Porter HK, Bi Y, Li M. Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China. Front Pharmacol. 2022;13:1013485. doi:10.3389/fphar.2022.1013485.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ren D, Chang X, Sun C, Liu R, Wang J, Zhang N. Willingness to pay for packaging cancer screening of Chinese rural residents. Cancer Med. 2023;12(3):3532–42. doi:10.1002/cam4.5162.
   PubMed Web of Science ®Google Scholar
• Rajamoorthy Y, Taib NM, Harapan H, Wagner AL, Munusamy S, Bashir MK. Application of the double bounded dichotomous choice model to the estimation of parent’s willingness to pay for the hand foot mouth disease vaccination: a survey in Selangor, Malaysia. PLoS One. 2023;18(6):18. doi:10.1371/journal.pone.0286924.
   Web of Science ®Google Scholar
• Frew EJ, Wolstenholme JL, Whynes DK. Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats. Health Policy. 2004;68(3):289–98. doi:10.1016/j.healthpol.2003.10.003.
   PubMed Web of Science ®Google Scholar
• The Standing Committee of the National People’s Congress. Vaccine administration act. [accessed 2019 Jul 2]. https://www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20190702121701506.html.
   Google Scholar
• Arbiol J, Yabe M, Nomura H, Borja M, Gloriani N, S-I Y. Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccine. Hum Vaccines Immunother. 2015;11(4):1046–56. doi:10.1080/21645515.2015.1010901.
   PubMed Web of Science ®Google Scholar
• Albers C. The problem with unadjusted multiple and sequential statistical testing. Nat Commun. 2019;10(1):10. doi:10.1038/s41467-019-09941-0.
   PubMedGoogle Scholar